SCHEMBL9050672

SCHEMBL9050672

CC1Oc2ccccc2C(=O)N1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 8/20 0.55
DRD3 P35462 5/20 0.54
DRD2 P14416 5/20 0.54
DRD5 P21918 2/20 0.54
DRD1 P21728 3/20 0.53
HTR1A P08908 7/20 0.52
HTR2A P28223 5/20 0.52
ADRA1A P35348 2/20 0.52
ADRA1D P25100 1/20 0.52
ADRA1B P35368 1/20 0.52
HTR6 P50406 3/20 0.52
SIGMAR1 Q99720 2/20 0.51
ABCB11 O95342 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CHRM1 P11229 1/20 0.50
TBXA2R P21731 1/20 0.50
SLC6A4 P31645 1/20 0.50
OPRM1 P35372 1/20 0.50
KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045178 0.79 DRD3 (0.62) HTR7DRD3DRD2DRD5DRD1
SCHEMBL9049248 0.76 DRD2 (0.71) HTR7DRD3DRD2DRD5DRD1
Hydrochloric Acid SCHEMBL9587355 0.75 DRD2 (0.69) HTR7DRD3DRD2DRD5DRD1
SCHEMBL11635491 0.74 HTR7 (0.59) HTR7DRD3DRD2DRD5DRD1
SCHEMBL9369051 0.74 DRD2 (0.63) HTR7DRD3DRD2DRD5DRD1
SCHEMBL10836050 0.74 HTR7 (0.72) HTR7DRD3DRD2DRD5DRD1
SCHEMBL21802017 0.74 HTR7 (0.76) HTR7DRD3DRD2DRD5DRD1
SCHEMBL11630613 0.72 HTR7 (0.73) HTR7DRD3DRD2DRD5DRD1
SCHEMBL8148701 0.72 DRD2 (0.57) HTR7DRD3DRD2DRD5DRD1
SCHEMBL11845590 0.72 ADRA1A (0.58) HTR7DRD3DRD2DRD5DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527081-B1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use PF MEDICAMENT (FR) 1996-01-03 EP claimed
US-5308844-A ANTIDEPRESSANT, ANXIOLYTIC AGENT, ANALGESIC, HYPOTENSIVE AGENT PIERRE FABRE MEDICAMENT (FR) 1994-05-03 US disclosed